305 related articles for article (PubMed ID: 15128491)
1. Hepatobiliary complications of cystic fibrosis.
Feranchak AP
Curr Gastroenterol Rep; 2004 Jun; 6(3):231-9. PubMed ID: 15128491
[TBL] [Abstract][Full Text] [Related]
2. Cholangiocyte biology and cystic fibrosis liver disease.
Feranchak AP; Sokol RJ
Semin Liver Dis; 2001 Nov; 21(4):471-88. PubMed ID: 11745036
[TBL] [Abstract][Full Text] [Related]
3. Animal models of gastrointestinal and liver diseases. Animal models of cystic fibrosis: gastrointestinal, pancreatic, and hepatobiliary disease and pathophysiology.
Olivier AK; Gibson-Corley KN; Meyerholz DK
Am J Physiol Gastrointest Liver Physiol; 2015 Mar; 308(6):G459-71. PubMed ID: 25591863
[TBL] [Abstract][Full Text] [Related]
4. Cystic fibrosis-associated liver disease.
Herrmann U; Dockter G; Lammert F
Best Pract Res Clin Gastroenterol; 2010 Oct; 24(5):585-92. PubMed ID: 20955961
[TBL] [Abstract][Full Text] [Related]
5. Expression of delta F508 cystic fibrosis transmembrane conductance regulator protein and related chloride transport properties in the gallbladder epithelium from cystic fibrosis patients.
Dray-Charier N; Paul A; Scoazec JY; Veissière D; Mergey M; Capeau J; Soubrane O; Housset C
Hepatology; 1999 Jun; 29(6):1624-34. PubMed ID: 10347100
[TBL] [Abstract][Full Text] [Related]
6. Cystic fibrosis-related liver disease: Clinical presentations, diagnostic and monitoring approaches in the era of CFTR modulator therapies.
Dana J; Debray D; Beaufrère A; Hillaire S; Fabre M; Reinhold C; Baumert TF; Berteloot L; Vilgrain V
J Hepatol; 2022 Feb; 76(2):420-434. PubMed ID: 34678405
[TBL] [Abstract][Full Text] [Related]
7. Gallbladder and bile duct disease in Cystic Fibrosis.
Assis DN; Debray D
J Cyst Fibros; 2017 Nov; 16 Suppl 2():S62-S69. PubMed ID: 28986023
[TBL] [Abstract][Full Text] [Related]
8. Pathophysiology of Cystic Fibrosis Liver Disease: A Channelopathy Leading to Alterations in Innate Immunity and in Microbiota.
Fiorotto R; Strazzabosco M
Cell Mol Gastroenterol Hepatol; 2019; 8(2):197-207. PubMed ID: 31075352
[TBL] [Abstract][Full Text] [Related]
9. Selective activation of cystic fibrosis transmembrane conductance regulator Cl- and HCO3- conductances.
Reddy MM; Quinton PM
JOP; 2001 Jul; 2(4 Suppl):212-8. PubMed ID: 11875262
[TBL] [Abstract][Full Text] [Related]
10. Clinical expression of cystic fibrosis in a large cohort of Italian siblings.
Terlizzi V; Lucarelli M; Salvatore D; Angioni A; Bisogno A; Braggion C; Buzzetti R; Carnovale V; Casciaro R; Castaldo G; Cirilli N; Collura M; Colombo C; Di Lullo AM; Elce A; Lucidi V; Madarena E; Padoan R; Quattrucci S; Raia V; Seia M; Termini L; Zarrilli F
BMC Pulm Med; 2018 Dec; 18(1):196. PubMed ID: 30577776
[TBL] [Abstract][Full Text] [Related]
11. Hepatobiliary disease in cystic fibrosis patients with pancreatic sufficiency.
Waters DL; Dorney SF; Gruca MA; Martin HC; Howman-Giles R; Kan AE; De Silva M; Gaskin KJ
Hepatology; 1995 Apr; 21(4):963-9. PubMed ID: 7535738
[TBL] [Abstract][Full Text] [Related]
12. The gallbladder and biliary tract in cystic fibrosis.
Curry MP; Hegarty JE
Curr Gastroenterol Rep; 2005 May; 7(2):147-53. PubMed ID: 15802104
[TBL] [Abstract][Full Text] [Related]
13. Liver cirrhosis and portal hypertension in cystic fibrosis.
Efrati O; Barak A; Modan-Moses D; Augarten A; Vilozni D; Katznelson D; Szeinberg A; Yahav J; Bujanover Y
Eur J Gastroenterol Hepatol; 2003 Oct; 15(10):1073-8. PubMed ID: 14501614
[TBL] [Abstract][Full Text] [Related]
14. CFTR Cl- channel function in native human colon correlates with the genotype and phenotype in cystic fibrosis.
Hirtz S; Gonska T; Seydewitz HH; Thomas J; Greiner P; Kuehr J; Brandis M; Eichler I; Rocha H; Lopes AI; Barreto C; Ramalho A; Amaral MD; Kunzelmann K; Mall M
Gastroenterology; 2004 Oct; 127(4):1085-95. PubMed ID: 15480987
[TBL] [Abstract][Full Text] [Related]
15. Cystic fibrosis transmembrane conductance regulator-mRNA delivery: a novel alternative for cystic fibrosis gene therapy.
Bangel-Ruland N; Tomczak K; Fernández Fernández E; Leier G; Leciejewski B; Rudolph C; Rosenecker J; Weber WM
J Gene Med; 2013; 15(11-12):414-26. PubMed ID: 24123772
[TBL] [Abstract][Full Text] [Related]
16. Genotype and phenotype in cystic fibrosis.
Zielenski J
Respiration; 2000; 67(2):117-33. PubMed ID: 10773783
[TBL] [Abstract][Full Text] [Related]
17. Cystic fibrosis transmembrane conductance regulator (CFTR) and renal function.
Stanton BA
Wien Klin Wochenschr; 1997 Jun; 109(12-13):457-64. PubMed ID: 9261986
[TBL] [Abstract][Full Text] [Related]
18. Hepatobiliary disease in patients with cystic fibrosis.
Moyer K; Balistreri W
Curr Opin Gastroenterol; 2009 May; 25(3):272-8. PubMed ID: 19381084
[TBL] [Abstract][Full Text] [Related]
19. Liver disease in cystic fibrosis.
Colombo C; Russo MC; Zazzeron L; Romano G
J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S49-55. PubMed ID: 16819402
[TBL] [Abstract][Full Text] [Related]
20. [Question 5. What management of hepatobiliary injury in the course of cystic fibrosis? Physiopathology and diagnostic criteria of hepatobiliary injury in the course of cystic fibrosis].
Belli DC
Arch Pediatr; 2003 Aug; 10 Suppl 3():487s-489s. PubMed ID: 14671964
[No Abstract] [Full Text] [Related]
[Next] [New Search]
